Navigation Links
Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences

WESTFORD, Mass., March 11 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that President and Chief Executive Officer Michael Davin and Chief Financial Officer Tim Baker will present at the following institutional investor conferences in March:

-- On Monday, March 17, the Company will present at the Cowen and Company

28th Annual Health Care Conference, taking place at The Boston Marriott

Copley Place. The presentation will begin at 2:30 p.m. ET.

-- On Wednesday, March 19, Cynosure will present at the Citi Investment

Research 2008 Small and Mid-Cap Conference, taking place at the Four

Seasons at Mandalay Bay, Las Vegas. The presentation will begin at

1:45 p.m. ET.

These presentations will be available via live audio webcast and archived replay through the "Investor Relations" section of Cynosure's website, To access the webcast, click on the link titled "Events."

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd: YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.

For corporate or product information, contact Cynosure at 800-886-2966, or visit


Scott Solomon

Vice President

Sharon Merrill Associates, Inc.


SOURCE Cynosure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
2. Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
3. Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference
4. Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
5. Mentice AB Announces Leadership Changes Within Its Worldwide Operations
6. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
7. Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults
8. Lilly Announces Termination of AIR Insulin Program
9. Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
10. Spectral announces 2007 financial results
11. Finesse Solutions, LLC Announces OPC Connectivity With Nova BioProfile 400
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... FAR HILLS, N.J. (PRWEB) , ... November 24, 2015 , ... ... University, as the recipient of the 2016 USGA Green Section Award. Presented annually since ... of golf through his or her work with turfgrass. , Clarke, of ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, December ... Helen Torley , president and CEO, will provide a corporate overview. ... New York at 1:00 p.m. ET/10:00 a.m. PT . ... investor relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... ... 24, 2015 , ... Copper is an essential micronutrient that ... proteins, copper is also toxic to cells. With a $1.3 million award from ... conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. aeruginosa), ...
Breaking Biology Technology:
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
(Date:11/9/2015)... , Nov. 09, 2015 ... the addition of the "Global Law ... their offering. --> ) ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) has ...
Breaking Biology News(10 mins):